Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |